Ompenaclid

Cat. No.: IBDI-436724

Ompenaclid (RGX-202) is an oral small-molecule SLC6A8 transporter inhibitor. Ompenaclid robustly inhibits creatine import in vitro and in vivo, reduces intracellular phosphocreatine and ATP levels, and induces tumor apoptosis. Ompenaclid can be used for the research of cancer and duchenne muscular dystrophy.

Product Details

Target	Apoptosis | Endogenous Metabolite
Molecular Weight	131.14
Appearance	Solid
Synonyms	RGX-202, 3-Guanidinopropionic acid
SMILES	O=C(O)CCNC(N)=N
Purity	≥98.0%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.